This is great news for Solbec, the renal cell carcinoma patient fron the Phase 1 trial with the 15 month ongoing response I guess was a compelling reason to grant orphan drug. It means total protection from competition in the US for coramsine on renal cell cancer.
SBP
solbec pharmaceuticals limited
This is great news for Solbec, the renal cell carcinoma patient...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)